ORGANOGENESIS HOLDINGS INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 18.67 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06
- ORGANOGENESIS HOLDINGS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 18.67M shares, a 10.01% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 19.13M shares, a 12.01% increase year-over-year.
- ORGANOGENESIS HOLDINGS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 16.97M shares.
- ORGANOGENESIS HOLDINGS INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 17.08M shares.
- ORGANOGENESIS HOLDINGS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 6.48M shares, a 57.05% decline from fiscal 2024.
- ORGANOGENESIS HOLDINGS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 15.09M shares, a 379.51% increase from fiscal 2023.
- ORGANOGENESIS HOLDINGS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 3.15M shares, a 8.64% decline from fiscal 2022.
- ORGANOGENESIS HOLDINGS INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 3.45M shares, a 246.54% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 18.67M shares 10-Q · filed 2026-08-06 | 18.67M shares 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | 19.13M shares 10-Q · filed 2026-05-07 | ||||
| 2025-12-31 | 6.48M shares 10-K · filed 2026-02-26 | ||||
| 2025-06-30 | 16.97M shares 10-Q · filed 2026-08-06 | 16.97M shares 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | 17.08M shares 10-Q · filed 2026-05-07 | ||||
| 2024-12-31 | 15.09M shares 10-K · filed 2026-02-26 | ||||
| 2023-12-31 | 3.15M shares 10-K · filed 2026-02-26 | ||||
| 2022-12-31 | 3.45M shares 10-K · filed 2024-02-29 | ||||
| 2022-09-30 | 4.38M shares 10-Q · filed 2022-11-09 | 3.48M shares 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | 3.76M shares 10-Q · filed 2022-08-09 | 3.38M shares 10-Q · filed 2022-08-09 | |||
| 2022-03-31 | 155.21K shares 10-Q · filed 2022-05-10 | ||||
| 2021-12-31 | 994.17K shares 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | 956.47K shares 10-Q · filed 2022-11-09 | 956.47K shares 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | 923.91K shares 10-Q · filed 2022-08-09 | 967.15K shares 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | 1.20M shares 10-Q · filed 2022-05-10 | ||||
| 2020-12-31 | 1.79M shares 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | 2.01M shares 10-Q · filed 2021-11-09 | 8.28M shares 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | 8.70M shares 10-Q · filed 2021-08-09 | 8.70M shares 10-Q · filed 2021-08-09 | |||
| 2020-03-31 | 7.17M shares 10-Q · filed 2021-05-11 | ||||
| 2019-12-31 | 7.18M shares 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | 7.26M shares 10-Q · filed 2020-11-09 | 7.26M shares 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | 25.01M shares 10-Q · filed 2020-08-10 | ||||
| 2019-03-31 | 24.94M shares 10-Q · filed 2020-05-11 | ||||
| 2018-12-31 | 25.73M shares 10-K · filed 2021-03-16 | 25.73M shares 10-K · filed 2019-03-18 | |||
| 2018-09-30 | 9.47M shares 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | 9.50M shares 10-Q · filed 2019-08-09 | ||||
| 2018-03-31 | 9.56M shares 10-Q · filed 2019-05-10 | ||||
| 2017-12-31 | 9.44M shares 10-K · filed 2020-03-09 | 9.44M shares 10-K · filed 2019-03-18 | |||
| 2016-12-31 | 6.72M shares 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |